NPI: 1154789659 · BROOKLAWN, NJ 08030 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/29/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/29/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,092 | $101K |
| 2019 | 4,499 | $252K |
| 2020 | 9,338 | $384K |
| 2021 | 13,605 | $469K |
| 2022 | 23,029 | $471K |
| 2023 | 13,921 | $447K |
| 2024 | 6,971 | $262K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,911 | 2,163 | $2.23M |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,960 | 613 | $67K |
| A4657 | Syringe, with or without needle, each | 5,315 | 1,484 | $28K |
| J1756 | Injection, iron sucrose, 1 mg | 7,304 | 1,213 | $19K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,967 | 756 | $9K |
| 85048 | 1,348 | 721 | $8K | |
| 85041 | 1,343 | 721 | $8K | |
| 83970 | 999 | 508 | $4K | |
| 82728 | 363 | 221 | $3K | |
| 83540 | 469 | 270 | $3K | |
| 83550 | 340 | 239 | $3K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,270 | 404 | $268.29 |
| OP250 | 3,568 | 106 | $0.00 | |
| 82108 | 12 | 12 | $0.00 | |
| 90661 | 16 | 15 | $0.00 | |
| 90674 | 79 | 43 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 135 | 77 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 56 | 26 | $0.00 |